The removal of low-concentration antibiotics from water to alleviate the potential threat of antibiotic-resistant bacteria and genes calls for the development of advanced treatment technologies with high efficiency. In this study, a novel graphene modified electro-Fenton (e-Fenton) catalytic membrane (EFCM) was fabricated for in situ degradation of low-concentration antibiotic florfenicol. The removal efficiency was 90%, much higher than that of electrochemical filtration (50%) and single filtration process (27%). This demonstrated that EFCM acted not only as a cathode for e-Fenton oxidation process in a continuous mode but also as a membrane barrier to concentrate and enhance the mass transfer of florfenicol, which increased its oxidation chances. The removal rate of florfenicol by EFCM was much higher (10.2 ± 0.1 mg m h) than single filtration (2.5 ± 0.1 mg m h) or batch e-Fenton processes (4.3 ± 0.05 mg m h). Long-term operation and fouling experiment further demonstrated the durability and antifouling property of EFCM. Four main degradation pathways of florfenicol were proposed by tracking the degradation byproducts. The above results highlighted the feasibility of this integrated membrane catalysis process for advanced water purification.
The
spread of Coronavirus disease 2019 (COVID-19) is caused by
severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting
in a global pandemic with around four million deaths. Although there
are a variety of nucleic acid-based tests for detecting SARS-CoV-2,
these methods have a relatively high cost and require expensive supporting
equipment. To overcome these limitations and improve the efficiency
of SARS-CoV-2 diagnosis, we developed a microfluidic platform that
collected serum by a pulling-force spinning top and paper-based microfluidic
enzyme-linked immunosorbent assay (ELISA) for quantitative IgA/IgM/IgG
measurements in an instrument-free way. We further validated the paper-based
microfluidic ELISA analysis of SARS-CoV-2 receptor-binding domain
(RBD)-specific IgA/IgM/IgG antibodies from human blood samples as
a good measurement with higher sensitivity compared with traditional
IgM/IgG detection (99.7% vs 95.6%) for early illness onset patients.
In conclusion, we provide an alternative solution for the diagnosis
of SARS-CoV-2 in a portable manner by this smart integration of pulling-force
spinning top and paper-based microfluidic immunoassay.
Efficient elimination of antibacterial activity of halogenated antibiotics by dehalogenation pretreatment is desired for a biochemical treatment process. In this study, crystalline cobalt phosphide nanosheet arrays on a Ti plate (C-CoP/Ti) are fabricated by a simple electrodeposition and phosphorization process. The crystalline structure greatly promotes atomic hydrogen (H*) generation. Moreover, the nanosheet arrays can provide abundant active sites and accelerate electron transfer and mass transport. As a result, the dehalogenation rate of florfenicol (FLO, an emerging organic pollutant) on C-CoP/Ti is 11.1, 2.97, and 13.6 times higher than that on amorphous CoP/Ti, Pd/Ti, and bare Ti, respectively. The C-CoP/Ti electrode achieves 97.4% dehalogenation of FLO (20 mg L −1 ) within 30 min at −1.2 V (vs Ag/AgCl). Nearly 100% of Cl and 20% of F are broken away within 120 min, showing the highest electrocatalytic defluorination efficiency reported so far. Both experimental results and theoretical calculations reveal that the dehalogenation of FLO on C-CoP/Ti is synergistically accomplished via direct reduction of electron transfer and indirect reduction of H*. This study develops a highly efficient non-noble metal electrode material for dehalogenation of halogenated organic compounds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.